Primary Care Clinics in North Kingstown, RI Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Robert B Trivett Family Medicine - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 35 Weaver Rd, North Kingstown, RI 02852 Phone: 401-295-9719 Fax: 401-295-0150 |
Wickford Family Medicine Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 320 Phillips St, Suite 204, North Kingstown, RI 02852 Phone: 401-450-2111 |
Wickford Internists, Inc. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 320 Phillips St, Suite 201, North Kingstown, RI 02852 Phone: 401-295-3120 Fax: 401-295-1230 |
J. D. Gloor, M. D., Inc. General Practice Medicare: Not Enrolled in Medicare Practice Location: 7260 Post Rd Ste 103, North Kingstown, RI 02852 Phone: 401-294-8200 Fax: 401-294-8222 |
Bayside Family Healthcare Dental Clinic/Center - Community Health Medicare: Not Enrolled in Medicare Practice Location: 308 Callahan Rd, North Kingstown, RI 02852 Phone: 401-295-9706 Fax: 401-295-0920 |
North Kingstown Family Practice Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 320 Phillips St, Ste 102, North Kingstown, RI 02852 Phone: 401-667-2537 Fax: 401-667-2538 |
Wickford Family Practice Llc Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 320 Phillips St Ste 102, North Kingstown, RI 02852 Phone: 603-667-6765 |
News Archive
Exposure to chemical in weedkiller Roundup raises risk of some cancers, study finds
Exposure to glyphosate-the world's most widely used, broad-spectrum herbicide and the primary ingredient in the weedkiller Roundup-increases the risk of some cancers by more than 40 percent, according to new research from the University of Washington.
Boehringer Ingelheim, Lilly announce new data from linagliptin Phase III study on type 2 diabetes
Boehringer Ingelheim and Eli Lilly and Company today announced Phase III study results for linagliptin, demonstrating improved glycaemic control in adults with type 2 diabetes (T2D) whose blood glucose is not adequately maintained.
Regence introduces Evolve to meet full spectrum of consumers' healthcare needs
Regence introduces Evolve, a new portfolio of individual health plans designed to meet the full spectrum of consumers' needs. From children needing preventative care, unemployed individuals seeking core coverage or a family searching for comprehensive benefits, Evolve has options to meet each unique situation.
Q BioMed signs definitive license agreement with Mannin Research
Q BioMed Inc., a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc.
StemCells to raise $12.5 million
StemCells, Inc. announced today that it has entered into an agreement to raise approximately $12.5 million in gross proceeds through the sale of approximately 10 million shares of its common stock to selected institutional investors at a price of $1.25 per share. The investors will also receive warrants to purchase approximately four million shares of common stock at an exercise price of $1.50 per share.
› Verified 2 days ago